プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Maria Chiara G.に依頼

Italy

MD, Ophthalmologist, PhD candidate

プロフィール概要

I am an eye doctor and PhD candidate. I have experience in writing scientific papers, preparing presentations and reports. I will use my experience to write or improve different types of medical or scientific texts aimed at a scientific audience. I also have experience in communicating science to a lay audience, which I learned during the science communication fellowship organised by the ARVO (association for research in vision and ophthalmology). I can also offer translation from Italian to English and vice versa.

専門分野

• ☆ Drug Development
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Orthoptics
• ☆ Ophthalmology
• ☆ Neuro-Ophthalmology
• ☆ Oncology
• ☆ Ophthalmic Surgery
• ☆ Ophthalmic Plastic & Reconstructive Surgery
• ☆ Inflammation
• ☆ Regulatory Writing
• ☆ Technical & Scientific Writing
• ☆ Science Communication

サービス

• Writing

Writing Medical Writing, Technical Writing, Copywriting, Translation

職務経験

PhD candidate

Leiden University Medical Center

1月 2021 - 現在

Medico in formazione (resident)

Università degli Studi di Siena

11月 2016 - 現在

学歴

Regulatory Writing Certificate

University of Chicago

10月 2023 - 3月 2024

Science Communication Training Fellowship

ARVO (Association for Research in Vision and Ophthalmology)

3月 2022 - 3月 2023

Winter School Data Ethics

Eurolife

1月 2023 - 1月 2023

Specializzazione in oftalmologia (Scienze mediche, chirurgiche e neuroscienze)

Università degli Studi di Siena

11月 2016 - 11月 2020

Laurea in medicina e chirurgia

Università degli Studi di Pavia

2009 - 2015

認定資格

• Basic course for clinical investigators (BROK) certification

  NFU - Nederlandse Federatie van Universitair Medische Centra

  9月 2022 - 現在

• Cambridge English Proficiency C2

  British Council

  12月 2010 - 現在

出版物

JOURNAL ARTICLE

Maria Chiara Gelmi, Robert M. Verdijk, Laurien E. Houtzagers, Pieter A. van der Velden, Wilma G. M. Kroes, Gregorius P. M. Luyten, T. H. Khanh Vu, Martine J. Jager (2023). Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma . International Journal of Molecular Sciences.

Maria Chiara Gelmi, Robert M Verdijk, Laurien Houtzagers, Pieter A. van der Velden, Wilma G. M. Kroes, Gregorius P. M. Luyten, T. H. Khanh Vu, Martine Jager (2023). Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma . International Journal of Molecular Sciences.

Maria Chiara Gelmi, Laurien E. Houtzagers, Thomas Strub, Imène Krossa, Martine J. Jager (2022). MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance . International Journal of Molecular Sciences.

Maria Chiara Gelmi, Laurien Houtzagers, Thomas Strub, Imène Krossa, Martine Jager (2022). MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance . International Journal of Molecular Sciences.

Wierenga, A.P.A., Brouwer, N.J., Gelmi, M.C., Verdijk, R.M., Stern, M.-H., Bas, Z., Malkani, K., van Duinen, S.G., Ganguly, A., Kroes, W.G.M., et al.(2022). Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color . Ophthalmology.

Miracco, C., Toti, P., Gelmi, M.C., Aversa, S., Baldino, G., Galluzzi, P., de Francesco, S., Petrelli, F., Sorrentino, E., Belmonte, G., et al.(2021). Retinoblastoma is characterized by a cold, CD8+ Cell Poor, PD-L1− microenvironment, which turns into hot, CD8+ cell rich, PD-L1+ after chemotherapy . Investigative Ophthalmology and Visual Science. 62. (2).

(2020). New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy . Mediators of inflammation.

Fabiani, C., Sota, J., Sainz-De-La-Maza, M., Pelegrín, L., Emmi, G., Lopalco, G., Iannone, F., Vannozzi, L., Guerriero, S., Gelmi, M.C., et al.(2020). New potential weapons for refractory scleritis in the era of targeted therapy . Mediators of Inflammation. 2020.

Francesco Martino, Maria Chiara Gelmi, Paolo Galluzzi, Sonia De Francesco, Clelia Miracco, Doris Hadjistilianou(2020). Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade Syndrome . Ocular Oncology and Pathology. 6. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 430--437. S. Karger {AG}

Martino, F., Gelmi, M.C., Galluzzi, P., De Francesco, S., Miracco, C., Hadjistilianou, D.(2020). Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade Syndrome . Ocular Oncology and Pathology. 6. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 430-437.

Fruschelli, M., Capozzoli, M., Gelmi, M.C., Masi, G., Annunziata, P.(2019). Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing–remitting multiple sclerosis . International Ophthalmology. 39. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 777-781.

Maria Chiara Gelmi, Mario Fruschelli, Marco Capozzoli, Gianni Masi, Pasquale Annunziata(2018). Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing–remitting multiple sclerosis . International Ophthalmology. Springer Nature

PREPRINT

Arwin Groenewoud, Gangyin Zhao, Maria-Chiara Gelmi, Jie Yin, Gerda E. M. Lamers, Remco van Doorn, Rob. M. Verdijk, Martine J. Jager, Felix B. Engel, B. Ewa Snaar-Jagalska (2023). Melanin enhances metastatic melanoma colonization by inhibiting ferroptosis .

OTHER

Maria Chiara Gelmi, Arwin Groenewoud, Jie Yin, Samar Alsafadi, Fariba Nemati, Didier Decaudin, Sergio Roman-Roman, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, et al.(2021). Patient-derived zebrafish xenograft models reveal ferroptosis as a fatal and druggable weakness in metastatic uveal melanoma . Cold Spring Harbor Laboratory

Groenewoud, A., Yin, J., Gelmi, M.C., Alsafadi, S., Nemati, F., Decaudin, D., Roman-Roman, S., Kalirai, H., Coupland, S.E., Jochemsen, A.G., et al.(2021). Patient-derived zebrafish xenograft models reveal ferroptosis as a fatal and druggable weakness in metastatic uveal melanoma . bioRxiv.